780 Mission St
San Francisco, CA 94103
APS Type 1 and Immune Tolerance: From Basic Biology to Clinical Translation
The APS Type 1 Foundation, with generous sponsorship by the Clinical Immunology Society and the National Institute of Allergy and Infectious Disease, is honored to host a FOCIS Member Society Symposium at the FOCIS 2024 Annual Meeting. Hosting this half day scientific symposium allows us to showcase our society, research and current initiatives.
Thank you to Drs. Anderson and Lionakis for helping to make this incredible opportunity possible.
Session Chairs
Mihalis Lionakis, MD
National Institute of Allergy and Infectious Diseases
Mark Anderson, MD, PhD
University of California, San Francisco
Session Agenda
Landscape of TEC development and differentiation
Corey Miller, MD, PhD
Assistant Professor, UCSF
TEC differentiation
Matthieu Giraud, PhD
Senior Researcher, Nantes Universite
Dynamics of thymic selection
Ellen Robey, PhD
Professor, UC Berkeley
Human TEC Development
Audrey Parent, PhD
Assistant Professor, UCSF
3:00 PM – 3:30 PM
Break
High throughput screening of APS1 and translation
Joe DeRisi, PhD
Professor, UCSF
Bill Robinson, MD, PhD
Professor, Stanford
Genetics of AIRE-deficiency
Sebastian Ochoa, MD
Assistant Professor, Baylor College of Medicine
Clinical Trial for APS1
Mihalis Lionakis MD, ScD
Senior Investigator, NIAID
For more information, please click here.